Skip to main content
. 2015 Feb 20;5(1):51–63. doi: 10.1159/000371509

Table 2.

Change from baseline in body composition and metabolic and inflammatory markers

CON (n = 25) EET (n = 17) PIO (n = 24) p value
EET vs. CON PIO vs. CON
Weight, kg −2.5 (−6.0, 1.0) −3.6 (−7.1, −0.1) −2.1 (−5.6, 1.4) 0.17 0.59
Fat mass, kg −2.3 (−5.2, 0.6) −3.7 (−6.6, −0.8) −1.8 (−4.7, 1.2) 0.03 0.31
Fat-free mass, kg −0.3 (−2.3, 1.7) 0.1 (−2.0, 2.1) −0.5 (−2.5, 1.6) 0.47 0.62
BMI −0.9 (−2.1, 0.4) −1.2 (−2.4, 0.1) −0.6 (−1.9, 0.6) 0.25 0.32
SBP, mm Hg −5.4 (−20, 9.4) −10 (−25, 4.5) −10 (−25, 4.4) 0.13 0.11
DBP, mm Hg 3.5 (−5.4, 12.5) 0.0 (−9.0, 9.1) 0.5 (−8.5, 9.6) 0.08 0.10
VO2 peak, l/min 0.0 (−0.4, 0.5) 0.2 (−0.2, 0.6) 0.0 (−0.4, 0.5) 0.11 0.99
VO2 peak, ml/kg/min 1.3 (−4.1, 6.7) 3.2 (−2.3, 8.7) 0.9 (−4.6, 6.4) 0.12 0.72

Metabolic markers
HbA1c, % −0.1 (−0.2, 0.0) −0.0 (−0.2, 0.1) −0.2 (−0.4, −0.1) 0.65 0.20
Leptin, ng/ml −0.4 (−4.2, 3.4) −0.5 (−5.0, 4.1) 0.5 (−3.4, 4.5) 0.99 0.72
Fasting glucose, mg/dl −1.4 (−3.7, 1.0) 0.7 (−2.1, 3.5) −2.3 (−4.7, 0.1) 0.27 0.60
Fasting insulin, μU/ml −0.4 (-3.2, 2.5) 3.3 (−0.0, 6.7) −6.7 (−9.6, −3.8) 0.10 0.003
Glucose disposal rate, mg/kg/min 0.1 (−0.6, 0.8) 0.7 (−0.1, 1.6) 1.7 (0.9, 2.4) 0.25 0.002
Total cholesterol, mg/dl −1.5 (−10.0, 6.9) −5.7 (−15.3, 3.8) −7.0 (−15.9, 1.9) 0.52 0.39
Triglycerides, mg/dl −21.9 (−39.9, −3.9) −24.3 (−44.8, −3.8) −28.5 (−47.5, −9.4) 0.86 0.62
HDL cholesterol, mg/dl 1.7 (−5.3, 8.7) −1.0 (−9.1, 7.1) −5.1 (−12.5, 2.2) 0.62 0.18
LDL cholesterol, mg/dl −0.5 (−2.7, 1.6) −2.0 (−4.4, 0.4) 0.6 (−1.6, 2.9) 0.38 0.46

Inflammatory markers
CRP, mg/l 1.4 (−2.2, 4.9) −1.0 (−5.3, 3.2) 2.9 (−0.8, 6.6) 0.39 0.55
1L-6, pg/ml −1.5 (−2.1, −1.0) −2.2 (−2.8, −1.5) −1.8 (−2.3, −1.2) 0.15 0.57
TNF-α, pg/ml 0.1 (−0.2, 0.4) −0.2 (−0.6, 0.2) −0.2 (−0.5, 0.1) 0.22 0.20

Values are unit change (95% CI). Estimates were done in a regression model controlling for baseline value, number of APOE ε4 alleles, and MCI subtype.